No. The SPC is designed to alleviate the relatively long period of clinical trials needed to secure marketing authorisation for a new medicine, by extending the legal protection provided by the patent. There is no provision for SPCs in domestic law, which does not currently allow for medicines to be patented (Article 3(1) of Act No. 606 of 20 June 1955 on patents).